Artikel
The functional and quality of life outcome of the ActiGait implantable drop foot stimulator for permanent central leg palsy
Suche in Medline nach
Autoren
Veröffentlicht: | 2. Juni 2015 |
---|
Gliederung
Text
Objective: The ActiGait drop foot stimulator is a promising technique for restoration of lost function by an implantable hybrid stimulation system. It allows an ankle dorsiflexion by active peroneal nerve stimulation during the swing phase of gait. Here, we report the outcome of the first prospective study on a larger number of patients with stroke-related drop foot.
Method: Twenty-seven stroke patients with persisting spastic leg paresis received an implantable ActiGait drop foot stimulator for restoration of ankle movement after successful surface test stimulation. After three to five weeks, the stimulator was activated and gait speed, gait endurance as well as the activation time of the system were evaluated and compared to preoperative gait tests. In addition, patient satisfaction was assessed using a questionnaire.
Results: Postoperative gait speed significantly improved from 33.9 sec/20m to 17.9 sec/20m (p<0.0001), gait endurance from 196 m/6min to 401 m/6min (p<0.0001), and activation time from 20.5 sec to 10.6 sec on average. In two patients with nerve injury, surgical repositioning of the electrode cuff became necessary. One patient showed a delayed wound healing and, in another patient, the system had to be removed because of a wound infection. Otherwise, no complications occurred during surgery and postoperative care. Marked improvement in mobility, social participation, and quality of life was confirmed by 89% to 96% of patients.
Conclusions: The ActiGait implantable drop foot stimulator improves gait speed, endurance, and quality of life in patients with stroke-related drop foot. Compared to foot orthosis or surface stimulation devices, the ActiGait system seems to be advantageous.
Note: K. Daniel Martin and Witold Polanski contributed equally to this work.